FDA Approves First Emergency Allergy Nasal Spray Neffy is a non-needle-based epinephrine treatment for anaphylaxis and other allergic reactions Aug 09, 2024
New Extended-Release Parkinson's Drug Approved Novel levodopa and carbidopa formulation led to more time without troublesome dyskinesia Aug 08, 2024
IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
FDA OKs Complement Inhibitor for IgA Nephropathy First-in-class iptacopan approved to reduce proteinuria in adults with rare progressive disease Aug 08, 2024
FDA Approves Vorasidenib for IDH-Mutant Gliomas Treatment improved PFS by 16 months compared with placebo in INDIGO trial Aug 06, 2024
Plant-based Food and Drink Labeling Is a Battlefield Public health considerations are missing in action Aug 06, 2024
Prescription-Free Online Semaglutide Is Risky Business Over 40% of pharmacy sites offering GLP-1 drug without a script are known to operate illegally Aug 05, 2024
FDA Advisors Mostly Convinced Arimoclomol Works for Rare Genetic Disorder If approved, this would be the first drug for Niemann-Pick disease type C Aug 03, 2024
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor Afamitresgene autoleucel (Tecelra) approved for metastatic synovial sarcoma Aug 02, 2024
FDA Panel to Consider Arimoclomol for Rare Genetic Disorder This is the second time the drug has been submitted to the FDA for Niemann-Pick disease type C Aug 01, 2024
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma Indicated for newly diagnosed patients who are eligible for stem cell transplant Jul 31, 2024
Heavy Metal in Chocolate; Trump 'No Doubt' Hit By Bullet; FDA Cinnamon Warning Grows Health news and commentary gathered by ľ¹ÏÖ±²¥ staff Jul 31, 2024
Alzheimer's Gets New Galantamine Drug Newly approved prodrug has dual mechanism of action to improve tolerability Jul 30, 2024
FDA Warns of Overdoses With Compounded Semaglutide Multi-dose vials pose complications for self-administration Jul 29, 2024
New Monthly Paliperidone Palmitate Injectable OK'd for Schizophrenia Long-acting intramuscular product approved for schizoaffective disorder as well Jul 29, 2024
FDA Approves Blood Test for Colon Cancer Screening Shield becomes the first liquid biopsy for primary CRC screening Jul 29, 2024
Veterans Lobby for Psychedelic Therapy, but Will It Influence MDMA's Approval? Hurdles remain for FDA application Jul 27, 2024
Third JAK Inhibitor for Alopecia Areata Wins FDA Approval Over 30% of patients had at least 80% scalp hair regrowth with deuruxolitinib Jul 26, 2024
FDA Panel Supports More Clarity in NSCLC Perioperative Immunotherapy Trials Committee unanimously backs mandating trial design to distinguish effects of therapy phases Jul 25, 2024
'Shambolic' Medical Meeting; DaVita Whistleblower Suit; FDA Mum on MDMA This past week in healthcare investigations Jul 24, 2024
FDA OKs First Orally Dissolving Birth Control Pill Opens up options for people who have trouble swallowing Jul 24, 2024
Trump Talks Cancer Cures, 'Right to Try' as He Accepts GOP Presidential Nomination "We're going to get to the bottom of it" Jul 19, 2024
FDA Allows Best-Selling E-Cigarette Vuse Alto, but Only in Tobacco Flavor Agency previously rejected the company's menthol-flavored products Jul 18, 2024
Anti-VEGF Ocular Implant for Age-Related Macular Degeneration to Return to Market Updates to device, refill syringe, manufacturing process restore function to expected level Jul 08, 2024
With the End of Chevron, Health and Environmental Experts' Hands Are Tied We need the rule of law to protect public health Jul 08, 2024
Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases? U.S. clinics market oligonucleotide therapy for a wide range of conditions, without much evidence Jul 05, 2024
Supreme Court to Weigh if FDA Was Heavy-Handed With Its Flavored E-Cig Regulations Agency is appealing a lower court ruling siding with vaping companies Jul 03, 2024
FDA OKs Another Drug for Early Alzheimer's Disease Decision gives patients a second anti-amyloid treatment option Jul 02, 2024
Supreme Court Decision May Have Sweeping Effects on Healthcare, Experts Say Chevron ruling curbs federal power, could upend drug approvals, Medicare drug price negotiation Jul 02, 2024
House Panel OKs Bills on Obesity Drug and Breakthrough Device Coverage in Medicare Meanwhile, CMS proposed rule on the device coverage, issued a year ago, awaits a final version Jul 01, 2024
FDA OKs First Point-of-Care Test for Detecting Hep C in At-Risk Adults Results as quick as 1 hour, enabling a test-and-treat approach Jun 27, 2024
FDA Warns Eye Bank for Taking Donors Who Had Sepsis All five donors should have been ineligible, FDA said Jun 27, 2024
FDA Approves Novel Nebulized Therapy for COPD First-in-class dual phosphodiesterase inhibitor lands broad indication for COPD maintenance Jun 27, 2024
Oncology Drug Shortages Persist, but Continue to Evolve Supply-chain issues, unrealistically low prices for generics, hoarding, other factors to blame Jun 26, 2024
Docs in Abortion Ban States Find Workarounds to Deliver Care A ľ¹ÏÖ±²¥ survey reveals surprising trends in reproductive care 2 years post-Roe Jun 24, 2024
Subcutaneous C5 Inhibitor Approved for PNH Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
New Treatment Approved for Chronic Inflammatory Demyelinating Polyneuropathy Efgartigimod injection reduced CIDP relapse risk Jun 23, 2024
Adagrasib Wins Accelerated Approval for KRAS-Mutant Colorectal Cancer KRAS inhibitor plus cetuximab achieved 34% response rate, 85% disease control in early trial Jun 21, 2024
FDA Authorizes First Menthol E-Cigarettes Meanwhile, HHS still has not issued a final rule banning menthol-flavored tobacco cigarettes Jun 21, 2024